Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillanceHideto Kameda, Yoshiya Tanaka, Naoki Soeda et al.|Modern Rheumatology|2023Cited by 4
Safety of sarilumab in a Japanese population with rheumatoid arthritis by age group: Data from an interim analysis of a postmarketing surveillance studyHideto Kameda, Yoshiya Tanaka, Sadatomo Tasaka et al.|Modern Rheumatology|2024Cited by 4